Parkinson's Disease: Global Therapeutic Development Analysis H2 2020 including Drug Profiles and Key Company Reviews
Share this article Share this article ResearchAndMarkets.com's offering. Report Highlights The Parkinson's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 11, 48, 62, 4, 224, 97 and 9 respectively. Similarly, the Universitie...
Source: prnewswire.com